 |
|
Search Term:
HO A.D. see all results for ho
|
Ho A.D.
|
|
Author
|
Adhesion of Human Hematopoietic Progenitor Cells to Mesenchymal Stromal Cells Involves CD44
|
|
Cells Tissues Organs 2008, Vol. 188, No. 1-2
|
|
Author
|
Antimicrobial Therapy in Neutropenic Patients
|
|
Supportive Care in Cancer Patients
|
|
Author
|
Assignment of the NAD-dependent deacetylase sirtuin 5 gene (SIRT5) to human chromosome band 6p23 by in situ hybridization
|
|
Cytogenetic and Genome Research 2006, Vol. 112, No. 3-4
|
|
Author
|
Ceftriaxone for the Treatment of Febrile Episodes in Nonneutropenic Patients with Hematooncological Disease or HIV Infection: Comparison of Outpatient and Inpatient Care
|
|
Chemotherapy 2001, Vol. 47, No. 3
|
|
Author
|
Central Venous Catheter-Related Complications
|
|
Supportive Care in Cancer Patients
|
|
Author
|
Centrosome Aberrations and Cancer
|
|
Onkologie 2001, Vol. 24, No. 6
|
|
Author
|
Chylous Ascites in a Patient with Inflammatory Myofibroblastic Tumor
|
|
Case Reports in Oncology 2009, Vol. 2, No. 2
|
|
Author
|
Deoxycoformycin in Therapy of Refractory Lymphoid Neoplasms
|
|
Onkologie 1988, Vol. 11, No. 1
|
|
Author
|
Early Prediction of Therapy Outcome in Patients with High-Risk Soft Tissue Sarcoma Using Positron Emission Tomography
|
|
Onkologie 2008, Vol. 31, No. 3
|
|
Author
|
Evaluation of Mineralized Collagen and -Tricalcium Phosphate as Scaffolds for Tissue Engineering of Bone Using Human Mesenchymal Stem Cells
|
|
Cells Tissues Organs 2004, Vol. 177, No. 2
|
|
Author
|
Intensivierte Konsolidierungstherapie für ALL-Hochrisikopatienten
|
|
Onkologie 1988, Vol. 11, No. 1
|
|
Author
|
Interferon für die Therapie der HCL
|
|
Onkologie 1988, Vol. 11, No. 1
|
|
Author
|
Is There an Indication for High-Dose Chemotherapy in the Treatment of Bone and Soft-Tissue Sarcoma?
|
|
Oncology 2005, Vol. 68, No. 2-3
|
|
Author
|
Large Institutional Experience with Dose-Intensive Chemotherapy and Stem Cell Support in the Management of Sarcoma Patients
|
|
Oncology 2007, Vol. 73, No. 1-2
|
|
Author
|
Mitoxantrone and VP-16 in Refractory Acute Myelogenous Leukemia
|
|
Onkologie 1986, Vol. 9, No. 3
|
|
Author
|
Mitoxantrone in the Treatment of Relapsed and Refractory Acute Leukemia
|
|
Onkologie 1985, Vol. 8, No. 3
|
|
Author
|
MR-tomographischer Nachweis von Knochenmarkinfiltrationen bei malignen Lymphomen
|
|
Onkologie 1989, Vol. 12, Suppl. 1
|
|
Author
|
Phase-III-Studie zur Chemotherapie niedrig-maligner Non-Hodgkin-Lymphome: Vergleich einer Vincristin- mit einer Vindesin-Kombinations- Chemotherapie
|
|
Onkologie 1987, Vol. 10, No. 6
|
|
Author
|
Primäre Behandlung der Haarzelleukämie mit niedrigdosiertem humanem rekombinantem Interferon-Alpha-2c (Hr-IFn Alpha 2c) im Vergleich zur Therapie nach Splenektomie
|
|
Onkologie 1987, Vol. 10, No. 1
|
|
Author
|
Recombinant Human Erythropoietin in the Treatment of Cancer
|
|
Supportive Care in Cancer Patients
|
|
Author
|
Successful Treatment of Bronchiolitis obliterans Organizing Pneumonia with Low-Dose Methotrexate in a Patient with Hodgkin's Disease
|
|
Oncology 2001, Vol. 61, No. 1
|
|
Author
|
The Stromal Activity of Mesenchymal Stromal Cells
|
|
Transfusion Medicine and Hemotherapy 2008, Vol. 35, No. 3
|
|
Author
|
Treatment of Chemotherapy-Induced Emesis
|
|
Supportive Care in Cancer Patients
|
|
Author
|
Treatment of Gastrointestinal Stromal Tumor with Imatinib Mesylate: A Retrospective Single-Center Experience in Heidelberg
|
|
Digestive Diseases 2006, Vol. 24, No. 1-2
|
|
Author
|
Use of Erythropoietin in Patients with Multiple Myeloma
|
|
Onkologie 2003, Vol. 26, No. 1
|
Ho A.D., Heidelberg
|
|
Editor
|
Deutsche, Österreichische und Schweizerische Gesellschaften für Hämatologie und Onkologie (2009)
|